AlphAIAlphAI — Financial news for AI agents
247wallst.com

Rezera sets $11 to $13 IPO range for a $200 million Nasdaq raise

Rezera Inc. set an IPO price range of $11 to $13 per share, aiming to raise $200 million on Nasdaq. The offering is led by four underwriters. The final price may vary based on demand during the roadshow.

Original reporting
247wallst.com
Published Nov 5, 2026, 11:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 12:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Rezera sets $11 to $13 IPO range for a $200 million Nasdaq raise — source image
Source · 247wallst.com
Decision brief

The 30-second read

Med
01

Why it matters

The disclosed range sets valuation expectations and informs allocation decisions for institutional investors ahead of final pricing.

02

Market read

First disclosure of the IPO price range provides actionable insight for investors considering participation in the offering.

03

What to watch

Bookrunner reputation and demand during roadshow could shift final price outside the range

Relevance 7/10Novelty 8/10Timing: ahead of pricing

Background

Rezera Inc. is preparing a $200 million Nasdaq IPO, filing an amended prospectus with a $11‑$13 price range.

Market effects

Sector

Potential impact on the broader tech IPO pipeline

Regional

Limited to US Nasdaq market participants

Global

Low

Counterpoint

What could challenge this read

Investors may wait for final pricing rather than commit based on range

Key entities

  • company
    Rezera Inc.

    Issuer of the upcoming Nasdaq IPO

  • financial_institution
    Jefferies

    Lead underwriter for the IPO

  • financial_institution
    TD Cowen

    Co‑underwriter for the IPO

  • financial_institution
    Cantor

    Co‑underwriter for the IPO

  • financial_institution
    Wedbush PacGrow

    Co‑underwriter for the IPO

Read at source← All news

Related articles

MedAI 8/10

What Microsoft's Texas decision means for Nscale's $35bn IPO

Microsoft declined to expand its contract with Nscale for a Texas data center, potentially worth tens of billions. Nscale, aiming for a $30B-$35B IPO, has faced setbacks with other major AI buyers. The company's backlog is heavily concentrated with Microsoft and Anthropic, raising concerns about growth and energy constraints. Political and grid issues in Texas and the UK add uncertainty. Nscale's IPO will test investor appetite for AI infrastructure. (349 characters)

capacityglobal.com
$ANTMedAI 8/10

Anthropic IPO: 12x Revenue, a $23B Loss in the Q3 Filing

Anthropic, an AI company, reported $16.96B revenue in Q3 2026, up 12x year-over-year, but posted a $23.3B net loss. The loss was largely due to accounting charges on convertible notes. Operating income swung from a $974M profit in Q2 to a $567M loss in Q3, driven by higher compute costs. The company plans to go public under the ticker ANT, with an IPO potentially valued at $2T.

memeburn.com
$ANTMedAI 8/10

Everything you need to know ahead of Anthropic's IPO

Anthropic, an AI startup, publicly filed for its IPO, aiming to debut on Nasdaq as early as Nov. 16, 2026, with the ticker symbol ANT. The company has not yet set a price or announced the number of shares to be sold. The IPO timeline could be affected by market conditions and regulatory approvals.

finance.yahoo.com